Radiation Oncology·Cleveland, OH

Case Western Reserve University/University Hospitals Cleveland Medical Center

Signal lift62%78%+16 pp with a signal here
Allocate signal →Track an away here22-26 pooled · applicant-level
Step 2 invited
p10 – p90
Sample N
55
applicant rows
This cycle
no tracked aways yet
Match rate
0.0%
no match data
01Cohort funnel2022-26 pooled · applicant-level
N = 55
Applied
55
100.0%
Invited
38
69.1%
Matched
0
0%

Steepest cliff: invite → match (100% of invitees did not match here). Interview prep and ranking strategy carry the weight.

J-1 visaH-1B visaF-1 visaAdvancedAcademic/Clinician Educator
Your fitCase Western Reserve University/University Hospitals Cleveland Medical Center Program

Create a free profile to see your personalized fit

Get started
Contact
LH
Program Director
Lauren Elizabeth Henke, MD, MS, MSc
Email director
DA
Program Coordinator
Dejalai Alexander, BA
Email coordinator
Training sites1 site · Cleveland
  • 1
    Case Western Reserve University/University Hospitals Cleveland Medical Center
    Cleveland, OH
    Primary
Interview invites
Loading...
Score rangesinvited cohort

Step 2 CK data not available

Level 2 CE data not available

Interview rates
US MD
0%
US DO
0%
US IMG
0%
Non-US IMG
0%
Interview prepRadiation Oncology
personalTell me about yourself.★ common
specialtyWhy did you choose this specialty?★ common
programWhy are you interested in our program?★ common
behavioralWhat are your strengths and weaknesses?★ common
personalWhere do you see yourself in 5-10 years?★ common
Community resourcesRadiation Oncology · 25-26
Save this program

Add Case Western Reserve University/University Hospitals Cleveland Medical Center to your list

Build a personal match list. Compare programs side-by-side, see how your timing stacks against peers, and get notified when peers hear back.

Next

Calculate your match probability for Radiation Oncology.

See how your profile compares across all programs.

Open calculator →

Data from NRMP 2025 Residency Explorer. Not medical advice. © 2026 Rezumab LLC.